Zoledronic Acid Accelerates ER Stress-Mediated Inflammation by Increasing PDE4B Expression in Bisphosphonate-Related Osteonecrosis of the Jaw.
BRONJ
ER stress
Inflammation
PDE4B
ZOL
Journal
Applied biochemistry and biotechnology
ISSN: 1559-0291
Titre abrégé: Appl Biochem Biotechnol
Pays: United States
ID NLM: 8208561
Informations de publication
Date de publication:
25 Mar 2024
25 Mar 2024
Historique:
accepted:
04
02
2024
medline:
25
3
2024
pubmed:
25
3
2024
entrez:
25
3
2024
Statut:
aheadofprint
Résumé
Long-term administration of bisphosphonates can lead to a significant side effect known as bisphosphonate-related osteonecrosis of the jaw (BRONJ). Although macrophage-mediated inflammation has been established as an important factor in BRONJ, the underlying mechanism remains elusive. In the current study, the roles of endoplasmic reticulum (ER) stress in zoledronic acid (ZOL)-induced inflammation were analyzed in macrophages, and the regulatory mechanism of ER stress activation was next investigated. An in vitro model of BRONJ was established by treating RAW264.7 cells with ZOL. The activation of ER stress was analyzed by western blotting and transmission electron microscopy, and inflammation was assessed by quantitative real-time PCR and enzyme-linked immunosorbent assay. ER stress was significantly activated in ZOL-treated macrophages, and inhibition of ER stress by TUDCA, an ER stress inhibitor, suppressed ZOL-induced inflammation in macrophages. Mechanistically, phosphodiesterase 4B (PDE4B) was significantly increased in ZOL-treated macrophages. Forced expression of PDE4B promoted ER stress and inflammation, whereas PDE4B knockdown decreased ZOL-induced ER stress and inflammation in macrophages. More importantly, PDE4B inhibitor could improve ZOL-induced BRONJ in vivo. These data suggest that ZOL accelerates ER stress-mediated inflammation in BRONJ by increasing PDE4B expression. PDE4B inhibition may represent a potential therapeutic strategy for BRONJ. Subsequent research should concentrate on formulating medications that selectively target PDE4B, thereby mitigating the risk of BRONJ in patients undergoing bisphosphonate treatment.
Identifiants
pubmed: 38523176
doi: 10.1007/s12010-024-04859-w
pii: 10.1007/s12010-024-04859-w
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Wang, L., Fang, D., Xu, J., & Luo, R. (2020). Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: A brief review. BMC Cancer, 20, 1059.
doi: 10.1186/s12885-020-07568-9
pubmed: 33143662
pmcid: 7607850
Singer, F. R. (2020). The evaluation and treatment of Paget’s disease of bone. Best Practice & Research Clinical Rheumatology, 34, 101506.
doi: 10.1016/j.berh.2020.101506
Dwan, K., Phillipi, C. A., Steiner, R. D., & Basel, D. (2016). Bisphosphonate therapy for osteogenesis imperfecta. Cochrane Database of Systematic Reviews, 10, CD005088.
pubmed: 27760454
Endo, Y., Kumamoto, H., Nakamura, M., Sugawara, S., Takano-Yamamoto, T., Sasaki, K., & Takahashi, T. (2017). Underlying mechanisms and therapeutic strategies for bisphosphonate-related osteonecrosis of the jaw (BRONJ). Biological &/and Pharmaceutical Bulletin, 40, 739–750.
doi: 10.1248/bpb.b16-01020
Koth, V. S., Figueiredo, M. A., Salum, F. G., & Cherubini, K. (2016). Bisphosphonate-related osteonecrosis of the jaw: from the sine qua non condition of bone exposure to a non-exposed BRONJ entity. Dento Maxillo Facial Radiology, 45, 20160049.
doi: 10.1259/dmfr.20160049
pubmed: 27167455
pmcid: 5606254
Campisi, G., Di Fede, O., Musciotto, A., Lo Casto, A., Lo Muzio, L., Fulfaro, F., Badalamenti, G., Russo, A., & Gebbia, N. (2007). Bisphosphonate-related osteonecrosis of the jaw (BRONJ): Run dental management designs and issues in diagnosis. Annals of Oncology, 18(Suppl 6), vi168-172.
doi: 10.1093/annonc/mdm250
pubmed: 17591816
Yunna, C., Mengru, H., Lei, W., & Weidong, C. (2020). Macrophage M1/M2 polarization. European Journal of Pharmacology, 877, 173090.
doi: 10.1016/j.ejphar.2020.173090
pubmed: 32234529
Yao, Y., Cai, X., Ren, F., Ye, Y., Wang, F., Zheng, C., Qian, Y., & Zhang, M. (2021). The macrophage-osteoclast axis in osteoimmunity and osteo-related diseases. Frontiers in Immunology, 12, 664871.
doi: 10.3389/fimmu.2021.664871
pubmed: 33868316
pmcid: 8044404
Boniakowski, A. E., Kimball, A. S., Jacobs, B. N., Kunkel, S. L., & Gallagher, K. A. (2017). Macrophage-mediated inflammation in normal and diabetic wound healing. The Journal of Immunology, 199, 17–24.
doi: 10.4049/jimmunol.1700223
pubmed: 28630109
Loi, F., Cordova, L. A., Pajarinen, J., Lin, T. H., Yao, Z., & Goodman, S. B. (2016). inflammation, fracture and bone repair. Bone, 86, 119–130.
doi: 10.1016/j.bone.2016.02.020
pubmed: 26946132
pmcid: 4833637
Shen, X., Zhu, W., Zhang, P., Fu, Y., Cheng, J., Liu, L., Xu, R., & Jiang, H. (2022). Macrophage miR-149–5p induction is a key driver and therapeutic target for BRONJ. JCI Insight, 7(16), e159865. https://doi.org/10.1172/jci.insight.159865
Shen, X., Shen, X., Li, B., Zhu, W., Fu, Y., Xu, R., Du, Y., Cheng, J., & Jiang, H. (2021). Abnormal macrophage polarization impedes the healing of diabetes-associated tooth sockets. Bone, 143, 115618.
doi: 10.1016/j.bone.2020.115618
pubmed: 32858254
Csordas, G., Weaver, D., & Hajnoczky, G. (2018). Endoplasmic reticulum-mitochondrial contactology: Structure and signaling functions. Trends in Cell Biology, 28, 523–540.
doi: 10.1016/j.tcb.2018.02.009
pubmed: 29588129
pmcid: 6005738
Rowland, A. A., & Voeltz, G. K. (2012). Endoplasmic reticulum-mitochondria contacts: function of the junction. Nature Reviews Molecular Cell Biology, 13, 607–625.
doi: 10.1038/nrm3440
pubmed: 22992592
pmcid: 5111635
Qi, Z., & Chen, L. (2019). Endoplasmic reticulum stress and autophagy. Advances in Experimental Medicine and Biology, 1206, 167–177.
doi: 10.1007/978-981-15-0602-4_8
pubmed: 31776985
Koksal, A. R., Verne, G. N., & Zhou, Q. (2021). Endoplasmic reticulum stress in biological processing and disease. Journal of Investigative Medicine, 69, 309–315.
doi: 10.1136/jim-2020-001570
pubmed: 33472886
Cao, S. S. (2015). Endoplasmic reticulum stress and unfolded protein response in inflammatory bowel disease. Inflammatory Bowel Diseases, 21, 636–644.
doi: 10.1097/MIB.0000000000000238
pubmed: 25581827
Lindholm, D., Korhonen, L., Eriksson, O., & Koks, S. (2017). Recent insights into the role of unfolded protein response in ER stress in health and disease. Frontiers in Cell and Developmental Biology, 5, 48.
doi: 10.3389/fcell.2017.00048
pubmed: 28540288
pmcid: 5423914
Adams, C. J., Kopp, M. C., Larburu, N., Nowak, P. R., & Ali, M. M. U. (2019). Structure and molecular mechanism of ER stress signaling by the unfolded protein response signal activator IRE1. Frontiers in Molecular Biosciences, 6, 11.
doi: 10.3389/fmolb.2019.00011
pubmed: 30931312
pmcid: 6423427
Walter, P., & Ron, D. (2011). The unfolded protein response: from stress pathway to homeostatic regulation. Science, 334, 1081–1086.
doi: 10.1126/science.1209038
pubmed: 22116877
Wu, T., Jiang, Y., Shi, W., Wang, Y., & Li, T. (2023). Endoplasmic reticulum stress: a novel targeted approach to repair bone defects by regulating osteogenesis and angiogenesis. Journal of Translational Medicine, 21, 480.
doi: 10.1186/s12967-023-04328-8
pubmed: 37464413
pmcid: 10353205
Iyer, S., & Adams, D. J. (2023). Bone and the unfolded protein response: in sickness and in health. Calcified Tissue International, 113, 96–109.
doi: 10.1007/s00223-023-01096-x
pubmed: 37243756
pmcid: 10326125
Diaz-Bulnes, P., Saiz, M. L., Lopez-Larrea, C., & Rodriguez, R. M. (2019). Crosstalk between hypoxia and ER stress response: a key regulator of macrophage polarization. Frontiers in Immunology, 10, 2951.
doi: 10.3389/fimmu.2019.02951
pubmed: 31998288
Aghaloo, T. L., Kang, B., Sung, E. C., Shoff, M., Ronconi, M., Gotcher, J. E., Bezouglaia, O., Dry, S. M., & Tetradis, S. (2011). Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat. Journal of Bone and Mineral Research, 26, 1871–1882.
doi: 10.1002/jbmr.379
pubmed: 21351151
Wang, R., Zhang, W., Ma, H., Zou, D., Zhang, Z., & Wang, S. (2022). Structural insights into the binding of zoledronic acid with RANKL via computational simulations. Frontiers in Molecular Biosciences, 9, 992473.
doi: 10.3389/fmolb.2022.992473
pubmed: 36200071
pmcid: 9527314
Livak, K. J., & Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 25, 402–408.
doi: 10.1006/meth.2001.1262
pubmed: 11846609
Chen, Y., Zhang, X., Yang, J., Feng, W., Deng, G., Xu, S., & Guo, M. (2023) Extracellular vesicles derived from selenium-deficient MAC-T cells aggravated inflammation and apoptosis by triggering the endoplasmic reticulum (ER) stress/PI3K-AKT-mTOR pathway in bovine mammary epithelial cells. Antioxidants (Basel), 12(12), 2077. https://doi.org/10.3390/antiox12122077
Xu, B., Qin, Y., Li, D., Cai, N., Wu, J., Jiang, L., Jie, L., Zhou, Z., Xu, J., & Wang, H. (2020). Inhibition of PDE4 protects neurons against oxygen-glucose deprivation-induced endoplasmic reticulum stress through activation of the Nrf-2/HO-1 pathway. Redox Biology, 28, 101342.
doi: 10.1016/j.redox.2019.101342
pubmed: 31639651
Chen, X., Zhu, W., Xu, R., Shen, X., Fu, Y., Cheng, J., Liu, L., & Jiang, H. (2021). Geranylgeraniol restores zoledronic acid-induced efferocytosis inhibition in bisphosphonate-related osteonecrosis of the jaw. Frontiers in Cell and Developmental Biology, 9, 770899.
doi: 10.3389/fcell.2021.770899
pubmed: 34805177
pmcid: 8595285
Zhu, W., Xu, R., Du, J., Fu, Y., Li, S., Zhang, P., Liu, L., & Jiang, H. (2019). Zoledronic acid promotes TLR-4-mediated M1 macrophage polarization in bisphosphonate-related osteonecrosis of the jaw. The FASEB Journal, 33, 5208–5219.
doi: 10.1096/fj.201801791RR
pubmed: 30624969
Yang, X., Xu, X., Chen, J., Wang, Q., Wang, G., Ai, X., Wang, X., & Pan, J. (2020). Zoledronic acid regulates the synthesis and secretion of IL-1beta through histone methylation in macrophages. Cell Death Discovery, 6, 47.
doi: 10.1038/s41420-020-0273-4
pubmed: 32566254
pmcid: 7289826
Iwasaki, Y., Suganami, T., Hachiya, R., Shirakawa, I., Kim-Saijo, M., Tanaka, M., Hamaguchi, M., Takai-Igarashi, T., Nakai, M., Miyamoto, Y., & Ogawa, Y. (2014). Activating transcription factor 4 links metabolic stress to interleukin-6 expression in macrophages. Diabetes, 63, 152–161.
doi: 10.2337/db13-0757
pubmed: 23990363
Woo, C. W., Cui, D., Arellano, J., Dorweiler, B., Harding, H., Fitzgerald, K. A., Ron, D., & Tabas, I. (2009). Adaptive suppression of the ATF4-CHOP branch of the unfolded protein response by toll-like receptor signalling. Nature Cell Biology, 11, 1473–1480.
doi: 10.1038/ncb1996
pubmed: 19855386
pmcid: 2787632
Ghosh, A. K., Garg, S. K., Mau, T., O’Brien, M., Liu, J., & Yung, R. (2015). Elevated endoplasmic reticulum stress response contributes to adipose tissue inflammation in aging. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 70, 1320–1329.
doi: 10.1093/gerona/glu186
pubmed: 25324219
Su, Y., Ding, J., Yang, F., He, C., Xu, Y., Zhu, X., Zhou, H., & Li, H. (2022). The regulatory role of PDE4B in the progression of inflammatory function study. Frontiers in Pharmacology, 13, 982130.
doi: 10.3389/fphar.2022.982130
pubmed: 36278172
pmcid: 9582262
Komatsu, K., Lee, J. Y., Miyata, M., Hyang Lim, J., Jono, H., Koga, T., Xu, H., Yan, C., Kai, H., & Li, J. D. (2013). Inhibition of PDE4B suppresses inflammation by increasing expression of the deubiquitinase CYLD. Nature Communications, 4, 1684.
doi: 10.1038/ncomms2674
pubmed: 23575688
Avila, D. V., Myers, S. A., Zhang, J., Kharebava, G., McClain, C. J., Kim, H. Y., Whittemore, S. R., Gobejishvili, L., & Barve, S. (2017). Phosphodiesterase 4b expression plays a major role in alcohol-induced neuro-inflammation. Neuropharmacology, 125, 376–385.
doi: 10.1016/j.neuropharm.2017.08.011
pubmed: 28807677
pmcid: 5797427
Myers, S. A., Gobejishvili, L., SaraswatOhri, S., Garrett Wilson, C., Andres, K. R., Riegler, A. S., Donde, H., Joshi-Barve, S., Barve, S., & Whittemore, S. R. (2019). Following spinal cord injury, PDE4B drives an acute, local inflammatory response and a chronic, systemic response exacerbated by gut dysbiosis and endotoxemia. Neurobiology of Disease, 124, 353–363.
doi: 10.1016/j.nbd.2018.12.008
pubmed: 30557659